Bilateral vs Unilateral CTR
Public ClinicalTrials.gov record NCT01961011. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Simultaneous Bilateral Versus Unilateral Carpal Tunnel Release: A Prospective Comparison of Early Pain and Limitations in Activities of Daily Living
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Carpal tunnel release is a well accepted treatment for median nerve compression at the wrist. With a prevalence of 50 per 1000, it is the most common compressive neuropathy. With a number of anatomic as well as systemic factors playing a role in the development of carpal tunnel syndrome, it is not surprising that there is a high incidence of bilaterality with this disease. Padua et al. reported that 87% of 266 consecutive cases had signs and symptoms of carpal tunnel syndrome in their contralateral hand. In patients who have bilateral carpal tunnel syndrome that has not responded to conservative treatment, surgical release is indicated. In such cases, a decision must be made whether to offer bilateral simultaneous surgical release or to stage the two affected hands to allow time to recover from each. The purpose of this study is to determine the differences in short term disability between having bilateral vs unilateral carpal tunnel release. With better understanding of the way in which patients are impaired, better recommendations may be made on which patients to indicate for simultaneous bilateral procedures and who would benefit from staging procedures, allowing the patient to recover from one hand prior to proceeding to surgery on the other hand.
Study identification
- NCT ID
- NCT01961011
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2012
- Primary completion
- Jun 30, 2013
- Completion
- Feb 28, 2014
- Last update posted
- Oct 10, 2013
2012 – 2014
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Washington University School of Medicine | St Louis | Missouri | 63130 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Carpal Tunnel Syndrome trials
Other public records listing Carpal Tunnel Syndrome. Sorted by last update posted; newest first. Not a recommendation.
- NCT03867539: Exparel and Education to Avoid Opioids After Carpal Tunnel Release Recruiting
- NCT04737239: Corticosteroid Injection Effectiveness in Carpel Tunnel Patients With Negative or Mild EMG Studies Recruiting
- NCT06208709: Carpal Arch Space Augmentation (CASA) Clinical Trial Recruiting
- NCT04206215: Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome Recruiting
- NCT06071468: Registry of the Patient Experience for Carpal Tunnel Release Active, not recruiting
- NCT05783245: Effect of Cooling Therapy for Post-Operative Pain in Open Carpal Tunnel Release Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01961011, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 10, 2013 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01961011 live on ClinicalTrials.gov.